We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-6.01%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$148M
AUM Growth
-$13.4M
(-8.3%)
Cap. Flow
+$5.17M
Cap. Flow
% of AUM
3.49%
Top 10 Holdings %
Top 10 Hldgs %
33.04%
Holding
120
New
14
Increased
23
Reduced
48
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$3.37M |
| 2 |
UPH
UpHealth, Inc.
UPH
|
+$2.17M |
| 3 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$1.55M |
| 4 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$1.35M |
| 5 |
Journey Medical
DERM
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VG
Vonage Holdings Corporation
VG
|
+$2.56M |
| 2 |
ZIXI
Zix Corporation
ZIXI
|
+$1.63M |
| 3 |
Vericel Corp
VCEL
|
+$997K |
| 4 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
+$585K |
| 5 |
OptimizeRx
OPRX
|
+$557K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.42% |
| 2 | Technology | 16.73% |
| 3 | Industrials | 7.3% |
| 4 | Consumer Staples | 6.91% |
| 5 | Communication Services | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
76
DELISTED
Cardiovascular Systems, Inc.
CSII
| $436K | 0.29% |
23,200
+1,433
| +7% | +$38.3K |
|
77
Magnite
MGNI
$2.8B
| $412K | 0.28% |
23,525
| – | – |
|
78
Johnson & Johnson
JNJ
$613B
| $393K | 0.27% |
2,300
| – | – |
|
79
Lantronix
LTRX
$252M
| $392K | 0.26% |
+50,000
| New | +$379K |
|
80
IRIDEX
IRIX
$14.4M
| $389K | 0.26% |
63,746
+1,500
| +2% | +$10.7K |
|
81
Baxter International
BAX
$14.5B
| $344K | 0.23% |
4,009
-358
| -8% | -$28.8K |
|
82
Tactile Systems Technology
TCMD
$672M
| $323K | 0.22% |
16,967
-725
| -4% | -$20.6K |
|
83
Vivos Therapeutics
VVOS
$6.42M
| $306K | 0.21% |
5,442
-418
| -7% | -$33.7K |
|
84
Asure Software
ASUR
$253M
| $282K | 0.19% |
36,000
-6,000
| -14% | -$52.5K |
|
|
PRTK
85
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $270K | 0.18% |
60,200
-16,000
| -21% | -$75.9K |
|
86
Medtronic
MDT
$110B
| $269K | 0.18% |
2,600
| – | – |
|
87
Fortress Biotech
FBIO
$91.7M
| $257K | 0.17% |
6,854
-1,733
| -20% | -$77.3K |
|
88
Quest Diagnostics
DGX
$25.6B
| $255K | 0.17% |
1,475
| – | – |
|
|
IMBI
89
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $255K | 0.17% |
42,500
-13,500
| -24% | -$82.7K |
|
90
Inogen
INGN
$182M
| $228K | 0.15% |
+6,700
| New | +$243K |
|
91
Dyadic International
DYAI
$38.6M
| $217K | 0.15% |
48,100
-200
| -0.4% | -$852 |
|
92
Costco
COST
$423B
| $216K | 0.15% |
+380
| New | +$195K |
|
93
BP
BP
$109B
| $204K | 0.14% |
7,650
| – | – |
|
94
Airgain
AIRG
$72.1M
| $165K | 0.11% |
15,500
-1,000
| -6% | -$10.8K |
|
95
Lumen
LUMN
$6.91B
| $159K | 0.11% |
+12,700
| New | +$162K |
|
|
CTEK
96
DELISTED
CynergisTek, Inc.
CTEK
| $151K | 0.1% |
105,000
-80,000
| -43% | -$128K |
|
97
Viatris
VTRS
$20.5B
| $143K | 0.1% |
10,546
| – | – |
|
|
VRAY
98
DELISTED
ViewRay, Inc.
VRAY
| $142K | 0.1% |
25,700
+200
| +0.8% | +$1.22K |
|
|
MIRO
99
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $103K | 0.07% |
21,880
-25,340
| -54% | -$180K |
|
|
NBSE
100
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $84K | 0.06% |
1,500
+450
| +43% | +$30.2K |
|
Similar funds
PWP
BF
SFG
HWMG
FTEA
WT
BAM
WLG
Perkins Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Perkins Capital Management held 120 positions worth $148M, down 8.3% from $162M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Perkins Capital Management deployed $5.17M of net new capital in Q4 2021, opening 14 new positions and adding to 23 existing holdings. Its largest new stake was UpHealth, Inc.: 93,945 shares worth $2.1M.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 62% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Vericel Corp, an estimated $997K trimmed.
- Perkins Capital Management's largest Q4 2021 buy was UpHealth, Inc.: 93,945 shares worth $2.1M.
- Perkins Capital Management added most to ASPEN GROUP, INC. in Q4 2021, an estimated $3.37M increase.
- Perkins Capital Management's biggest Q4 2021 reduction was Vericel Corp, cutting an estimated $997K.
- Perkins Capital Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $2.56M.
- Perkins Capital Management's ten largest holdings make up 33% of its $148M portfolio in Q4 2021.
- Perkins Capital Management opened 14 new positions and closed 11 in Q4 2021.
- Perkins Capital Management's portfolio value fell 8.3% quarter-over-quarter to $148M.
Based on Perkins Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.